Clinical Outcomes Based on Multigene Profiling in Metastatic Breast Cancer Patients.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.15_suppl.1524
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

The Impacts of Inclusion in Clinical Trials on Outcomes Among Patients With Metastatic Breast Cancer (MBC)

PLoS ONE
Multidisciplinary
2016English

An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers

Frontiers in Medicine
Medicine
2018English

Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2008English

Molecular Profiling of Breast Cancer: Clinical Implications

British Journal of Cancer
Cancer ResearchOncology
2004English

Antibody-Based Cell-Surface Proteome Profiling of Metastatic Breast Cancer Primary Explants and Cell Lines

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2018English

Impact of Body Composition on Clinical Outcomes in Metastatic Renal Cell Cancer

Oncologist
Cancer ResearchMedicineOncology
2011English

Excision of the Primary Tumour in Patients With Metastatic Breast Cancer: A Clinical Dilemma

Current Oncology
Oncology
2012English

Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Scientific Reports
Multidisciplinary
2019English

A Multigene Predictor of Metastatic Outcome in Early Stage Hormone Receptor-Negative and Triple-Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy